Amass
Life sciences research data
Agents search biomedical papers, clinical trials, drugs and regulatory approvals to map a therapeutic area.
- Map the landscape for oral GLP-1 agonists in obesity: approved, in trials, patents
- Make the case for and against KRAS G12D as a drug target
- What has changed for semaglutide since first approval?
How it works
Click Connect and log in on Amass’s own page. By default each person connects their own account, and an agent acts as whoever asked it.
- Developer
- Amass Technologies ApS
- Category
- Science
- How it connects
- Log in with Amass
- Agents can
- Read, and change what an admin allows
- Website
- amass.tech
